Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Theresa Grover

Concepts (335)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Intensive Care Units, Neonatal
34
2025
268
3.810
 Why?
Hernias, Diaphragmatic, Congenital
16
2025
208
3.710
 Why?
Extracorporeal Membrane Oxygenation
7
2025
344
1.560
 Why?
Infant, Newborn
56
2025
6260
1.520
 Why?
Infant, Premature
13
2025
598
1.520
 Why?
Cross Infection
3
2025
253
1.340
 Why?
Bacterial Infections
2
2025
244
1.270
 Why?
Catheterization, Central Venous
5
2021
115
1.180
 Why?
Bronchopulmonary Dysplasia
10
2024
402
1.110
 Why?
Urinary Tract Infections
4
2025
194
1.050
 Why?
Pulmonary Circulation
15
2011
425
0.930
 Why?
Gestational Age
16
2025
952
0.880
 Why?
Enteral Nutrition
4
2025
201
0.880
 Why?
Mycoses
1
2025
86
0.870
 Why?
Central Venous Catheters
4
2021
50
0.830
 Why?
Catheter-Related Infections
4
2017
91
0.770
 Why?
Gastroschisis
4
2025
32
0.720
 Why?
Length of Stay
10
2025
1264
0.710
 Why?
Catheterization, Peripheral
1
2021
109
0.620
 Why?
Quality Improvement
9
2024
1234
0.620
 Why?
Hypertension, Pulmonary
11
2021
1939
0.610
 Why?
Bottle Feeding
1
2019
20
0.600
 Why?
Fetus
14
2020
797
0.590
 Why?
Infant Formula
1
2019
71
0.570
 Why?
Vascular Endothelial Growth Factor A
6
2007
547
0.560
 Why?
Bacteremia
4
2024
216
0.540
 Why?
Practice Guidelines as Topic
6
2024
1545
0.540
 Why?
Infant
25
2025
9796
0.540
 Why?
Postoperative Complications
5
2025
2824
0.540
 Why?
Lung
10
2011
4042
0.530
 Why?
Hospitals, Pediatric
5
2025
534
0.530
 Why?
Parenteral Nutrition, Total
1
2017
26
0.520
 Why?
Retrospective Studies
28
2025
16389
0.500
 Why?
Weight Gain
2
2017
536
0.500
 Why?
Vasodilation
11
2011
512
0.490
 Why?
Sheep
20
2011
868
0.490
 Why?
Intensive Care, Neonatal
4
2020
40
0.460
 Why?
High-Frequency Ventilation
1
2015
45
0.450
 Why?
Intersectoral Collaboration
1
2015
59
0.440
 Why?
Infant, Premature, Diseases
2
2024
107
0.440
 Why?
Developmental Disabilities
1
2018
285
0.440
 Why?
Patient Education as Topic
1
2019
769
0.420
 Why?
Nitric Oxide Synthase
9
2006
241
0.400
 Why?
Tracheostomy
3
2024
143
0.400
 Why?
Endothelial Growth Factors
2
2002
64
0.390
 Why?
Anti-Bacterial Agents
4
2024
1864
0.380
 Why?
Lymphokines
2
2002
131
0.380
 Why?
Hospitalization
3
2021
2259
0.380
 Why?
Patient Discharge
6
2025
914
0.360
 Why?
Humans
59
2025
141010
0.360
 Why?
Nitric Oxide
10
2011
894
0.360
 Why?
Surgical Procedures, Operative
1
2014
270
0.350
 Why?
Female
49
2025
75619
0.340
 Why?
Intercellular Signaling Peptides and Proteins
2
2002
387
0.340
 Why?
Pulmonary Artery
11
2011
1115
0.330
 Why?
Intubation, Intratracheal
2
2024
298
0.320
 Why?
Parents
1
2019
1439
0.320
 Why?
Persistent Fetal Circulation Syndrome
2
2011
138
0.300
 Why?
Anesthesia
2
2023
248
0.300
 Why?
Pregnancy
23
2021
7034
0.280
 Why?
Survival Rate
4
2018
1971
0.280
 Why?
Respiration, Artificial
5
2024
689
0.270
 Why?
Patient Care Bundles
2
2019
28
0.270
 Why?
Lung Diseases
1
2014
783
0.270
 Why?
Male
28
2025
69945
0.270
 Why?
Databases, Factual
6
2024
1445
0.260
 Why?
Guideline Adherence
4
2025
560
0.250
 Why?
Nitric Oxide Synthase Type III
6
2007
199
0.250
 Why?
Fibrin
1
2007
90
0.250
 Why?
Fetal Diseases
3
2004
180
0.250
 Why?
Guanylate Cyclase
4
2011
38
0.230
 Why?
Logistic Models
6
2025
2097
0.230
 Why?
Pulmonary Alveoli
2
2005
391
0.230
 Why?
Infection Control
2
2017
166
0.230
 Why?
Bradycardia
2
2024
52
0.230
 Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2007
287
0.220
 Why?
Anastomotic Leak
1
2024
43
0.220
 Why?
Ventilator Weaning
1
2024
39
0.220
 Why?
Ductus Arteriosus, Patent
1
2025
53
0.220
 Why?
Esophageal Atresia
1
2024
26
0.220
 Why?
North America
1
2025
304
0.210
 Why?
Hospital Mortality
2
2019
928
0.210
 Why?
Tracheoesophageal Fistula
1
2024
33
0.210
 Why?
Stenosis, Pulmonary Vein
1
2024
19
0.210
 Why?
Blood Culture
1
2024
24
0.210
 Why?
Consensus
2
2024
546
0.210
 Why?
Critical Pathways
1
2025
108
0.210
 Why?
Cyclic GMP
4
2011
91
0.210
 Why?
Clinical Protocols
1
2025
273
0.210
 Why?
Laryngoscopy
1
2024
121
0.200
 Why?
Ductus Arteriosus
6
2008
73
0.200
 Why?
Neovascularization, Pathologic
1
2004
295
0.200
 Why?
Multivariate Analysis
4
2024
1504
0.190
 Why?
Delphi Technique
1
2024
313
0.190
 Why?
Hemangioendothelioma
1
2002
13
0.180
 Why?
Infant, Newborn, Diseases
1
2023
113
0.180
 Why?
Time Factors
7
2024
6939
0.180
 Why?
Infant, Small for Gestational Age
2
2025
103
0.180
 Why?
Uterus
1
2002
221
0.170
 Why?
Patient Handoff
1
2021
39
0.170
 Why?
Hepatitis B Vaccines
1
2021
43
0.170
 Why?
Retrognathia
1
2020
5
0.170
 Why?
Animals, Newborn
7
2009
866
0.170
 Why?
Neuromuscular Blockade
1
2021
45
0.170
 Why?
Severity of Illness Index
5
2024
2903
0.170
 Why?
Social Determinants of Health
1
2024
274
0.170
 Why?
Hepatitis B
1
2021
67
0.170
 Why?
Micrognathism
1
2020
19
0.170
 Why?
Betamethasone
1
2000
21
0.160
 Why?
Benzoates
2
2011
49
0.160
 Why?
Analgesia
1
2021
104
0.160
 Why?
Vascular Resistance
6
2011
364
0.160
 Why?
Ventricular Septum
1
2019
8
0.160
 Why?
Carbon Monoxide
1
2000
83
0.160
 Why?
Hypothermia
1
2020
48
0.150
 Why?
United States
7
2025
15252
0.150
 Why?
Incidence
2
2018
2802
0.150
 Why?
Cooperative Behavior
3
2017
455
0.150
 Why?
Food, Fortified
1
2019
42
0.150
 Why?
Neonatology
1
2019
29
0.150
 Why?
Geographic Mapping
1
2019
27
0.150
 Why?
Blood Pressure
5
2019
1740
0.150
 Why?
Airway Obstruction
1
2020
166
0.140
 Why?
Receptors, Cytoplasmic and Nuclear
2
2011
207
0.140
 Why?
Endothelium, Vascular
1
2005
941
0.140
 Why?
Animals
22
2011
37304
0.140
 Why?
Recombinant Proteins
4
2005
1362
0.140
 Why?
Respiratory Insufficiency
1
2021
325
0.140
 Why?
Community-Acquired Infections
1
2020
176
0.140
 Why?
Housing
1
2019
146
0.140
 Why?
Echocardiography, Doppler
1
2018
113
0.140
 Why?
Perioperative Care
1
2020
228
0.130
 Why?
Odds Ratio
2
2020
1057
0.130
 Why?
Patient Transfer
1
2019
171
0.130
 Why?
Cardiopulmonary Resuscitation
1
2020
332
0.130
 Why?
Infant, Very Low Birth Weight
1
2017
70
0.130
 Why?
Continuity of Patient Care
1
2019
282
0.130
 Why?
Premature Birth
1
2020
363
0.130
 Why?
Patient Readmission
2
2019
695
0.130
 Why?
Disease Models, Animal
6
2011
4400
0.120
 Why?
Echocardiography
1
2019
647
0.120
 Why?
Heart Arrest
1
2020
389
0.120
 Why?
Infant, Extremely Premature
1
2017
66
0.120
 Why?
Hemodynamics
6
2011
1105
0.120
 Why?
Glucocorticoids
1
2000
534
0.120
 Why?
Child
8
2023
22337
0.120
 Why?
Antimicrobial Stewardship
1
2018
121
0.120
 Why?
Risk Adjustment
1
2016
81
0.120
 Why?
Liver Neoplasms
1
2002
741
0.120
 Why?
Vasoconstriction
2
2008
215
0.120
 Why?
Clinical Nursing Research
1
2015
12
0.110
 Why?
Communication
1
2021
941
0.110
 Why?
Ligation
3
2025
93
0.110
 Why?
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
3
2011
28
0.110
 Why?
Enterocolitis, Necrotizing
2
2024
40
0.110
 Why?
Enzyme Activation
3
2005
784
0.100
 Why?
Nitroarginine
5
2006
57
0.100
 Why?
rho-Associated Kinases
3
2011
81
0.100
 Why?
Pregnancy Complications, Cardiovascular
2
2004
83
0.100
 Why?
Premedication
2
2024
42
0.100
 Why?
Program Evaluation
1
2017
919
0.100
 Why?
Vascular Endothelial Growth Factors
2
2002
79
0.100
 Why?
Heart Defects, Congenital
1
2020
880
0.100
 Why?
Mothers
1
2019
776
0.090
 Why?
Administration, Inhalation
2
2007
594
0.090
 Why?
Isoenzymes
2
2011
296
0.090
 Why?
Vasodilator Agents
2
2011
330
0.090
 Why?
Pneumonia
1
2018
634
0.090
 Why?
Apgar Score
2
2023
18
0.090
 Why?
Enzyme Inhibitors
5
2009
833
0.090
 Why?
Health Services Accessibility
1
2019
1022
0.080
 Why?
Leadership
1
2015
387
0.080
 Why?
Sulfones
3
2005
127
0.080
 Why?
Pyridines
4
2011
555
0.080
 Why?
Infant, Low Birth Weight
2
2022
145
0.080
 Why?
Chronic Disease
2
2014
1806
0.080
 Why?
Prevalence
3
2024
2792
0.080
 Why?
Treatment Outcome
5
2025
11195
0.080
 Why?
Myocytes, Smooth Muscle
1
2011
258
0.080
 Why?
Magnetic Resonance Imaging
1
2022
3731
0.080
 Why?
Serotonin
1
2011
289
0.080
 Why?
Pulmonary Wedge Pressure
2
2009
67
0.070
 Why?
Amides
2
2006
97
0.070
 Why?
Cohort Studies
4
2021
5795
0.070
 Why?
Muscle, Smooth, Vascular
3
2009
445
0.070
 Why?
Immunohistochemistry
2
2002
1723
0.070
 Why?
Procollagen-Proline Dioxygenase
1
2007
24
0.070
 Why?
Estradiol
2
2001
523
0.060
 Why?
Immediate-Early Proteins
1
2007
48
0.060
 Why?
Cardiovascular Agents
1
2008
157
0.060
 Why?
Oxadiazoles
3
2011
35
0.060
 Why?
Case-Control Studies
2
2024
3575
0.060
 Why?
Comorbidity
2
2024
1671
0.060
 Why?
Selenium
1
2025
49
0.060
 Why?
Hydroxyeicosatetraenoic Acids
1
2005
36
0.060
 Why?
Protein Kinase Inhibitors
2
2008
918
0.060
 Why?
Risk Factors
3
2024
10475
0.050
 Why?
Thoracoscopy
1
2024
58
0.050
 Why?
Hyperoxia
1
2005
92
0.050
 Why?
Pyrazoles
2
2005
482
0.050
 Why?
Chylothorax
1
2024
20
0.050
 Why?
Antibiotic Prophylaxis
1
2025
122
0.050
 Why?
Anastomosis, Surgical
1
2024
158
0.050
 Why?
Birth Weight
1
2007
511
0.050
 Why?
Continuous Positive Airway Pressure
1
2024
92
0.050
 Why?
Noninvasive Ventilation
1
2024
59
0.050
 Why?
Body Weight
2
2005
992
0.050
 Why?
Video Recording
1
2024
197
0.050
 Why?
Intracellular Signaling Peptides and Proteins
1
2006
465
0.050
 Why?
Homeodomain Proteins
1
2007
514
0.050
 Why?
Parenteral Nutrition
1
2024
105
0.050
 Why?
Chromones
1
2002
44
0.050
 Why?
Platelet-Derived Growth Factor
1
2003
86
0.050
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2002
108
0.050
 Why?
Linear Models
1
2024
855
0.050
 Why?
Acetaminophen
1
2025
263
0.050
 Why?
Clinical Trials as Topic
1
2007
1035
0.050
 Why?
Morpholines
1
2002
129
0.050
 Why?
Oligonucleotides
1
2002
147
0.040
 Why?
Airway Extubation
1
2022
60
0.040
 Why?
Drug Administration Schedule
2
2001
771
0.040
 Why?
Prostaglandins
1
2001
97
0.040
 Why?
Estrogen Antagonists
1
2001
45
0.040
 Why?
Gastroesophageal Reflux
1
2024
244
0.040
 Why?
Artifacts
1
2022
133
0.040
 Why?
Cardiac Catheterization
1
2025
542
0.040
 Why?
Respiration
1
2022
209
0.040
 Why?
Image Enhancement
1
2022
191
0.040
 Why?
Soluble Guanylyl Cyclase
2
2011
15
0.040
 Why?
Piperazines
3
2011
374
0.040
 Why?
Phosphatidylinositol 3-Kinases
1
2002
364
0.040
 Why?
Postoperative Period
1
2021
359
0.040
 Why?
Dose-Response Relationship, Drug
3
2011
2047
0.040
 Why?
Injections, Intra-Arterial
1
2000
26
0.040
 Why?
Protoporphyrins
1
2000
16
0.040
 Why?
Prognosis
2
2019
4073
0.040
 Why?
Epinephrine
1
2020
147
0.040
 Why?
Quinoxalines
2
2011
67
0.040
 Why?
Perioperative Period
1
2020
69
0.040
 Why?
Benzodiazepines
1
2021
162
0.040
 Why?
Injections, Intramuscular
1
2000
139
0.040
 Why?
Airway Management
1
2020
79
0.040
 Why?
Proteus
1
2019
6
0.040
 Why?
Enterobacter
1
2019
8
0.040
 Why?
Pain Management
1
2023
397
0.040
 Why?
DNA-Binding Proteins
1
2007
1483
0.040
 Why?
Transportation of Patients
1
2020
65
0.040
 Why?
Heart Septal Defects, Ventricular
1
2019
45
0.040
 Why?
Colorado
2
2020
4595
0.040
 Why?
Aftercare
1
2021
218
0.040
 Why?
Body Temperature Regulation
1
2020
102
0.040
 Why?
Body Temperature
1
2020
224
0.040
 Why?
RNA, Messenger
1
2007
2815
0.040
 Why?
Hypnotics and Sedatives
1
2021
215
0.040
 Why?
Contrast Media
1
2022
475
0.040
 Why?
Benchmarking
1
2020
179
0.040
 Why?
Receptors, Estrogen
1
2001
411
0.040
 Why?
Reference Values
1
2000
803
0.040
 Why?
Cesarean Section
1
2000
213
0.040
 Why?
Ultrasonography, Prenatal
1
2020
291
0.040
 Why?
Blood Vessels
1
2000
173
0.040
 Why?
Infectious Disease Transmission, Vertical
1
2020
186
0.040
 Why?
Surgical Mesh
1
2018
52
0.040
 Why?
Operating Rooms
1
2020
147
0.030
 Why?
Imaging, Three-Dimensional
1
2022
565
0.030
 Why?
Program Development
1
2020
364
0.030
 Why?
Sterilization
1
2017
24
0.030
 Why?
Gene Expression Regulation, Developmental
1
2002
873
0.030
 Why?
Drug Utilization
1
2018
166
0.030
 Why?
Congenital Abnormalities
1
2018
105
0.030
 Why?
Diagnosis, Differential
1
2002
1490
0.030
 Why?
Hydrogen-Ion Concentration
1
2018
550
0.030
 Why?
Risk Assessment
2
2018
3512
0.030
 Why?
Acetylcholine
2
2009
204
0.030
 Why?
Patient Care Team
1
2021
664
0.030
 Why?
Infant Mortality
1
2017
121
0.030
 Why?
Regression Analysis
1
2018
1013
0.030
 Why?
3',5'-Cyclic-GMP Phosphodiesterases
2
2005
18
0.030
 Why?
Staphylococcus aureus
1
2019
434
0.030
 Why?
Burns
1
2020
350
0.030
 Why?
Cyclic Nucleotide Phosphodiesterases, Type 5
2
2005
22
0.030
 Why?
Sildenafil Citrate
2
2005
59
0.030
 Why?
Escherichia coli
1
2019
829
0.030
 Why?
Prenatal Exposure Delayed Effects
1
2001
656
0.030
 Why?
Purines
2
2005
182
0.030
 Why?
Survival Analysis
1
2017
1322
0.030
 Why?
Cells, Cultured
2
2011
4149
0.020
 Why?
Analgesics, Opioid
1
2021
1117
0.020
 Why?
Vaccination
1
2021
1467
0.020
 Why?
Ketanserin
1
2011
12
0.020
 Why?
Serotonin 5-HT2 Receptor Antagonists
1
2011
10
0.020
 Why?
Hysterotomy
1
2011
9
0.020
 Why?
Sertraline
1
2011
28
0.020
 Why?
Receptors, Serotonin
1
2011
34
0.020
 Why?
Prostaglandin-Endoperoxide Synthases
2
2001
73
0.020
 Why?
Nitroprusside
1
2011
72
0.020
 Why?
Fluoxetine
1
2011
56
0.020
 Why?
Hypertrophy, Right Ventricular
2
2003
147
0.020
 Why?
Kidney
1
2018
1480
0.020
 Why?
Adrenal Cortex Hormones
1
2013
501
0.020
 Why?
Hydrogen Peroxide
1
2011
334
0.020
 Why?
Prospective Studies
1
2021
7797
0.020
 Why?
Constriction
1
2008
47
0.020
 Why?
Indoles
1
2011
472
0.020
 Why?
Signal Transduction
3
2006
5114
0.020
 Why?
Child, Preschool
1
2022
11474
0.020
 Why?
Regional Blood Flow
1
2008
497
0.020
 Why?
Phosphoric Diester Hydrolases
1
2004
50
0.010
 Why?
Organ Size
1
2005
476
0.010
 Why?
Neovascularization, Physiologic
1
2005
179
0.010
 Why?
Drug Combinations
1
2005
365
0.010
 Why?
Heart Atria
1
2004
144
0.010
 Why?
Blood Flow Velocity
1
2004
411
0.010
 Why?
Receptor, Platelet-Derived Growth Factor beta
1
2003
29
0.010
 Why?
Receptor, Platelet-Derived Growth Factor alpha
1
2003
45
0.010
 Why?
Meclofenamic Acid
1
2001
9
0.010
 Why?
8-Bromo Cyclic Adenosine Monophosphate
1
2001
21
0.010
 Why?
Aorta
1
2004
423
0.010
 Why?
Cyclooxygenase 1
1
2001
26
0.010
 Why?
Infusions, Intra-Arterial
1
2001
61
0.010
 Why?
Cyclooxygenase Inhibitors
1
2001
81
0.010
 Why?
Intramolecular Oxidoreductases
1
2001
66
0.010
 Why?
Pulmonary Ventilation
1
2001
83
0.010
 Why?
Cyclooxygenase 2
1
2001
172
0.010
 Why?
Organ Specificity
1
2001
310
0.010
 Why?
Cytochrome P-450 Enzyme System
1
2001
157
0.010
 Why?
Ligands
1
2003
665
0.010
 Why?
Drug Interactions
1
2001
403
0.010
 Why?
Physical Stimulation
1
2000
68
0.010
 Why?
Rats, Sprague-Dawley
1
2005
2511
0.010
 Why?
Stress, Mechanical
1
2001
487
0.010
 Why?
Muscle, Smooth
1
2000
150
0.010
 Why?
Blotting, Western
1
2001
1220
0.010
 Why?
Gene Expression
1
2003
1490
0.010
 Why?
Rats
1
2005
5556
0.010
 Why?
Grover's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (335) concept(s)
_
Co-Authors Expand Description
See all (34) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)